GAP43 and schizophrenia: Although GAP43 is mainly expressed in the nervous system, studies have found that metabolites such as proteins in the brain of patients with schizophrenia enter the cerebrospinal fluid through the damaged blood-brain barrier, and its specific changes dynamically reflect the metabolic state of the brain and the stability of the internal environment [12, 13].